29
Participants
Start Date
March 8, 2017
Primary Completion Date
March 28, 2019
Study Completion Date
March 28, 2019
SC-006
Intravenous
ABBV-181
Intravenous
Carolina BioOncology Institute /ID# 202712, Huntersville
Washington University-School of Medicine /ID# 160883, St Louis
Oklahoma University /ID# 202713, Oklahoma City
University of California, Los Angeles /ID# 160882, Los Angeles
Highlands Oncology Group /ID# 201182, Fayetteville
University of Michigan Hospitals /ID# 167101, Ann Arbor
Mayo Clinic - Rochester /ID# 160884, Rochester
Memorial Sloan Kettering Cancer Center /ID# 160881, New York
Tennessee Oncology-Nashville Centennial /ID# 160880, Nashville
Lead Sponsor
AbbVie
INDUSTRY